Spot Trading’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,355
Closed -$254K 3990
2014
Q3
$254K Sell
2,355
-266
-10% -$34.7K ﹤0.01% 3026
2014
Q2
$318K Buy
+2,621
New +$316K ﹤0.01% 3020

Other funds holding ARCT

Spot Trading's ARCT Position: Q4 2014 in Review

Spot Trading sold out of Arcturus Therapeutics (ARCT) in Q4 2014, closing a stake of 2,355 shares — an estimated $254K sold.

Spot Trading first reported a position in ARCT in Q2 2014 and held it in 2 quarters. The position peaked at $318K in Q2 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q4 2014.

  • Spot Trading reported no remaining Arcturus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 2,355 Arcturus Therapeutics shares in Q4 2014, an estimated $254K.
  • Spot Trading first reported a position in Arcturus Therapeutics in Q2 2014 and held it in 2 quarters.
  • Spot Trading's Arcturus Therapeutics position peaked at $318K in Q2 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.